Related Experiment Video
Updated: Aug 28, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Inflammatory and Metabolic Biomarkers Associated with In-Hospital Mortality in Patients Hospitalized with Heart
Elena Cojocaru1, Victorița Șorodoc1,2, Cristian Cojocaru1
1Grigore T. Popa University of Medicine and Pharmacy, 700115 Iași, Romania.
Abstract:
Background/Objectives: Inflammatory and metabolic abnormalities are common in patients hospitalized with heart failure (HF), particularly during episodes of decompensation. Their associations with short-term in-hospital outcomes remain incompletely understood. Methods: We retrospectively reviewed 499 patients with documented chronic HF who were admitted for acute medical conditions between January and May 2024. The cohort was not limited to patients admitted for HF exacerbation; patients were classified as having compensated or decompensated HF at admission. Body mass index (BMI) was available for 498 patients, whereas HF status at admission was available for all 499 patients. Clinical, metabolic, and laboratory parameters were analyzed, with particular attention to C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and N-terminal pro-B-type natriuretic peptide (NT-proBNP). Patients were stratified according to BMI category (<25 kg/m2 or ≥25 kg/m2) and HF status at admission. Associations with all-cause in-hospital mortality were evaluated using multivariable logistic regression analysis. Results: Patients with decompensated HF at admission had higher CRP, NLR, PLR, SII, and NT-proBNP levels, as well as lower hemoglobin and eGFR values. All-cause in-hospital mortality was numerically higher in patients with BMI < 25 kg/m2 than in those with BMI ≥ 25 kg/m2 (8.4% vs. 4.2%), but the difference was not statistically significant (Pearson's χ2 test, p = 0.063). In adjusted analyses, CRP and SII were associated with all-cause in-hospital mortality, whereas NT-proBNP was not. Patients with higher BMI more often had glycemic and lipid abnormalities, whereas those with lower BMI had a more pronounced inflammatory profile. The apparent area under the curve (AUC) values were 0.793 for the CRP-based model and 0.814 for the SII-based model; after bootstrap correction, the optimism-corrected AUC values were 0.729 and 0.754, respectively. Conclusions: Higher CRP and SII levels were associated with all-cause in-hospital mortality after adjustment for selected clinical variables.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure III: Clinical Manifestations
Pathophysiology of Heart Failure